Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Barrière is a wellness and personal protection company founded in 2020 that specializes in medical-grade face masks and transdermal supplement patches. The company utilizes a proprietary transdermal delivery platform designed to bypass the digestive system, allowing active ingredients like vitamins, adaptogens, and enzymes to enter the bloodstream directly through the skin. Their innovative product line includes the first-ever lactose intolerance patch, as well as patches for NAD+ replenishment, sleep, and immunity. Barrière's products are sold through major retailers such as Walmart and are manufactured in MHRA-registered facilities in the United Kingdom. The brand distinguishes itself by combining clinical efficacy and science-backed formulations with stylish, wearable designs to encourage consistent daily wellness routines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Barrière.